Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Breast cancer recurrent risk assessment 21 gene detection primer and application thereof

A technology of risk assessment and genetic detection, which is applied in the determination/inspection of microorganisms, biochemical equipment and methods, DNA/RNA fragments, etc., can solve the problems of high recurrence and transfer rates, shorten the time of detection experiments, improve efficiency, expand conditionally consistent effect

Inactive Publication Date: 2017-08-18
温州迪安医学检验所有限公司 +1
View PDF4 Cites 13 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

In recent years, the incidence rate in my country has been increasing year by year. Although clinical research has made great progress, the recurrence and metastasis rates are still high.
In the past 20 years, the multidisciplinary comprehensive treatment model centered on surgery and assisted by chemotherapy, radiotherapy, and endocrine therapy has been greatly developed, which has significantly reduced the recurrence and mortality of breast cancer, but there is still a lack of effective methods to accurately predict breast cancer. The patient's risk of recurrence and treatment accordingly

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Breast cancer recurrent risk assessment 21 gene detection primer and application thereof
  • Breast cancer recurrent risk assessment 21 gene detection primer and application thereof
  • Breast cancer recurrent risk assessment 21 gene detection primer and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0050] Example 1: Detecting the nucleic acid sequences of the 21 genes detected in breast cancer recurrence risk assessment.

[0051] 21 pairs of specific primers were entrusted to Yingwei Jieji (Shanghai) Trading Co., Ltd. to synthesize:

[0052] SEQ ID NO: 1 5'-CGGACTTTGGGTGCGACTT-3'

[0053] SEQ ID NO: 2 5'-TTACAACTCTTCCACTGGGACGAT-3'

[0054] SEQ ID NO: 3 5'-GCTAGAGGCATCATGGACCGA-3'

[0055] SEQ ID NO: 4 5'-GAAGGACACAAGACCCGCTGA-3'

[0056] SEQ ID NO: 5 5'-AGAACTGGCCCTTCTTGGAGG-3'

[0057] SEQ ID NO: 6 5'-TCTATGGGGTCGTCATCTGGC-3'

[0058] SEQ ID NO: 7 5'-TTCAGGTTGTTGCAGGAGAC-3'

[0059] SEQ ID NO: 8 5'-CATCTTCTTGGGCACACAAT-3'

[0060] SEQ ID NO: 9 5'-GCCGAGATCGCCAAGATG-3'

[0061] SEQ ID NO: 10 5'-CTTTTGATGGTAGAGTTCCAGTGATTC-3'

[0062] SEQ ID NO: 11 5'-CCATCTGCATCCATCTTGTT-3'

[0063] SEQ ID NO: 12 5'-GGCCACCAGGGTATTATCTG-3'

[0064] SEQ ID NO: 13 5'-CGGTGTGAGAAGTGCAGCAA-3'

[0065] SEQ ID NO: 14 5'-CCTCTCGCAAGTGCTCCAT-3'

[0066] SEQ ID NO: 15 5'-TGTCCAGCCACC...

Embodiment 2

[0094] Example 2: 21-gene detection method for breast cancer recurrence risk assessment.

[0095] Instrument: Roche 480 fluorescent quantitative PCR detector, BECKMAN 22R desktop micro-refrigerated centrifuge, Eppendorf 5810R desktop refrigerated centrifuge, Taicang Hualida Laboratory Equipment Company WH-866 vortex oscillator.

[0096] (1) Paraffin tissue RNA extraction reagent

[0097] Paraffin tissue RNA was extracted according to the instructions of the paraffin tissue RNA extraction kit produced by Qiagen Biological Company, and tissue RNA was obtained for future use.

[0098] (2) reverse transcription, the reagents were purchased from THERMO company

[0099] The reaction system is a 20 μL system, including 11 μL template RNA, 1 μL RT enzyme, 1 μL RI enzyme, 2 μL dNTP, 4 μL 5×buffer, and 1 μL random primer; reaction conditions: 42°C for 30 min, 95°C for 5 min.

[0100] Prepare 3 tubes for one specimen.

[0101] (3) Fluorescent quantitative PCR, the reagents were pu...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a breast cancer recurrent risk assessment 21 gene detection primer and application thereof. The breast cancer recurrent risk assessment 21 gene detection primer comprises a nucleotide sequence as shown in an SEQ ID NO.: 1 to 42, and belongs to the technical field of molecular detection. The detection primer provided by the invention utilizes the advantage of fluorescent quantitation, and adopts fluorescent quantitation polymerase chain reaction to carry out amplification detection on 21 genes for breast cancer recurrent risk assessment, so that whether clinical measurements such as adjuvant chemotherapy are needed or not is considered. A kit provides a PCR (Polymerase Chain Reaction) amplification primer sequence of the 21 genes for breast cancer recurrent risk assessment, and the primer is applicable to detecting ER positive patients, HER2 negative patients, axillary node negative patients, moderately and poorly differentiated patients with the tumor size being 0.6 to 1.0cm and adverse prognostic factors, or patients with the tumor size is larger than 1cm, has the advantages of high sensitivity and specificity, stability, promptness, convenience in operation and the like, can well meet the clinical application of breast cancer recurrent risk assessment, and can be beneficial for reducing invalid medication administration, improving medication administration accuracy, and reducing financial burdens of the patients.

Description

technical field [0001] The invention belongs to the technical field of molecular detection, and in particular relates to a detection kit specially used for the nucleic acid sequence of breast cancer recurrence risk assessment 21 gene. Background technique [0002] Breast cancer is a major malignant tumor that endangers women's health. About 1.2 million women worldwide suffer from breast cancer every year, and 500,000 people die from breast cancer. The average mortality rate of breast cancer in my country is 2.61 / 100,000, and the mortality rate in several coastal cities is significantly higher, and the mortality rate in cities is 1.4 times higher than that in rural areas. In recent years, the incidence rate in my country has been increasing year by year. Although clinical research has made great progress, the recurrence and metastasis rates are still high. In the past 20 years, the multidisciplinary comprehensive treatment model centered on surgery and assisted by chemothera...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C12Q1/68C12N15/11
CPCC12Q1/6851C12Q1/6886C12Q2600/118C12Q2531/113C12Q2545/101C12Q2563/107
Inventor 任绪义虞闰六施宏
Owner 温州迪安医学检验所有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com